Search / 255 results found

from
to
  • Updated

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 17 to 21, 2022. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.

  • Updated

FRIDAY, Jan. 21, 2022 (HealthDay News) -- The risk for hospitalization for COVID-19 among older Americans is far higher for those who are unvaccinated than for those who are fully vaccinated and have had a booster shot, new government data show.

  • Updated

FRIDAY, Jan. 21, 2022 (HealthDay News) -- For young children with peanut allergy, initiation of peanut oral immunotherapy is associated with an increase in desensitization and remission, according to a study published in the Jan. 22 issue of The Lancet.

FRIDAY, Jan. 21, 2022 (HealthDay News) -- Vaccine effectiveness against symptomatic COVID-19 decreases by 20 weeks after the second dose of BNT162b2 or CHAdOx1-S, but limited waning is seen against COVID-19-related hospitalization and death, according to a study published online Jan. 12 in the New England Journal of Medicine.

FRIDAY, Jan. 21, 2022 (HealthDay News) -- The risk of hospitalization for COVID-19 among older Americans is far higher for those who are unvaccinated than for those who are fully vaccinated and have had a booster shot, new government data shows.

  • Updated

FRIDAY, Jan. 21, 2022 (HealthDay News) -- Herd immunity against COVID-19 is unlikely, and coping with the disease will likely hinge on vaccination, treatment and ensuring adequate hospital capacity, a new study conducted in Los Angeles County claims.